Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67

8 references·7 citing·48 second hop

FromToDepth

this work references cited by second hop

References

1981The Framing of Decisions and the Psychology of Choice17,834 cited
1985The Framing of Decisions and the Psychology of Choice1,252 cited
1992Choice under Conflict: The Dynamics of Deferred Decision1,013 cited
2007Assessing the economic challenges posed by orphan drugs279 cited
1995Maximizing health benefits vs egalitarianism: An Australian survey of health issues263 cited
2005Orphan drugs and the NHS: should we value rarity?229 cited
1996Cost-Effectiveness Analysis in a Setting of Budget Constraints — Is It Equitable?225 cited
2005Drugs for exceptionally rare diseases: do they deserve special status for funding?220 cited

Cited by

2014Orphan drugs policies: a suitable case for treatment84 cited
2017HTA programme response to the challenges of dealing with orphan medicinal products: Process evaluation in selected European countries83 cited
2020Establishing a reasonable price for an orphan drug78 cited
2015Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation77 cited
2012Orphan Drugs for Rare Diseases74 cited
2014Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

73 cited

2016Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries67 cited